David Erlinge
331 – 340 of 473
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Clinical and Biomedical Mass Spectrometry - New Frontiers in Drug Developments and Diagnosis
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
High glucose and free fatty acids induce beta cell apoptosis via autocrine effects of ADP acting on the P2Y(13) receptor.
(
- Contribution to journal › Article
- 2012
-
Mark
Farnesyl pyrophosphate is an endogenous antagonist to ADP-stimulated P2Y12 receptor-mediated platelet aggregation.
(
- Contribution to journal › Article
-
Mark
Translational platelet research in patients with coronary artery disease: hat are the rnalor knowledge gaps?
(
- Contribution to journal › Scientific review
-
Mark
Prognostic impact of early ventricular fibrillation in patients with ST-elevation myocardial infarction treated with primary PCI.
(
- Contribution to journal › Article
-
Mark
Platelet Function During Extended Prasugrel and Clopidogrel Therapy for Patients With ACS Treated Without Revascularization The TRILOGY ACS Platelet Function Substudy
(
- Contribution to journal › Article
-
Mark
Reduction in Platelet Reactivity With Prasugrel 5 mg in Low-Body-Weight Patients Is Noninferior to Prasugrel 10 mg in Higher-Body-Weight Patients: Results From the FEATHER Trial.
(
- Contribution to journal › Article
-
Mark
Target temperature management after out-of-hospital cardiac arrest-a randomized, parallel-group, assessor-blinded clinical trial-rationale and design
(
- Contribution to journal › Article
-
Mark
Rationale and Design of the 'MITOCARE' Study: A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of TRO40303 for the Reduction of Reperfusion Injury in Patients Undergoing Percutaneous Coronary Intervention for Acute Myocardial Infarction
(
- Contribution to journal › Article
-
Mark
TRITON and Beyond: New Insights into the Profile of Prasugrel.
(
- Contribution to journal › Article